John Stagg

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Oncoimmunology

Nature communications

Science immunology

Nature reviews. Clinical oncology

Université de Montréal

Université McGill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Montréal Aug 01 2010

Canada

Associate Professor :: Faculy of Pharmacy

Education History

Université McGill Jan 01 2000 - May 30 2005

Canada

PHD

Publications

David Allard, Isabelle Cousineau, Eric H Ma, Bertrand Allard, Yacine Bareche, Hubert Fleury, John Stagg
The CD73 immune checkpoint promotes tumor cell metabolic fitness. eLife 12 (2023)
Michael C Warren, Stephan Matissek, Matthew P Rausch, Marisella Panduro, R J Hall, Austin Dulak, David Brennan, Sonia Das Yekkirala, Secil Koseoglu, Ricard Masia, Yu Yang, Navamallika Reddy, Robert Prenovitz, Jamie Strand, Tauqueer Zaidi, Erik Devereaux, Célia Jacoberger Foissac, John Stagg, Benjamin H Lee, Pamela Holland, Vito J Palombella, Andrew C Lake
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties. ImmunoHorizons 7 (5) (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Fran Ois P Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine J Piccart
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial. Nature communications 14 (1) (2023)
John Stagg, Encouse Golden, Erik Wennerberg, Sandra Demaria
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology 8 (85) (2023)
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Monica L Guzman, Kevin J Harrington, Fernanda G Herrera, Jamie Honeychurch, Theodore S Hong, Lorea Iturri, Elisabeth Jaffee, Sana D Karam, Simon R V Knott, Constantinos Koumenis, David C Lyden, Ariel E Marciscano, Alan A Melcher, Michele Mondini, Anna Mondino, Zachary S Morris, Sean P Pitroda, Sergio A Quezada, Laura Santambrogio, Stephen L Shiao, John Stagg, Irma Telarovic, Robert Timmerman, Marie-Catherine Vozenin, Ralph R Weichselbaum, James Welsh, Anna C Wilkins, Chris Xu, Roberta Zappasodi, Weiping Zou, Alexandre Bobard, Sandra Demaria, Lorenzo Galluzzi, Eric Deutsch, Sylvia C Formenti
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference. Oncoimmunology 12 (1) (2023)
Turan Aghayev, Aleksandra M Mazitova, Jennifer R Fang, Iuliia O Peshkova, Matthew Rausch, Man Hsin Hung, Kerry F White, Ricard Masia, Elizaveta K Titerina, Aliia R Fatkhullina, Isabelle Cousineau, Simon Turcotte, Dmitry Zhigarev, Anastasiia Marchenko, Svetlana Khoziainova, Peter Makhov, Yin Fei Tan, Andrew V Kossenkov, David L Wiest, John Stagg, Xin Wei Wang, Kerry S Campbell, Amiran K Dzutsev, Giorgio Trinchieri, Jonathan A Hill, Sergei I Grivennikov, Ekaterina K Koltsova
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma. Cancer discovery 12 (8) (2022)
Dan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, Luke Anderson-Trocme, Marine Lingrand, Diana Berry, Lucas J M Perus, Yuhong Wei, Cleber Moraes, Rached Alkallas, Shivshankari Rajkumar, Dongmei Zuo, Matthew Dankner, Eric Hongbo Xu, Nicholas R Bertos, Hamed S Najafabadi, Simon Gravel, Santiago Costantino, Martin J Richer, Amanda W Lund, Sonia V Del Rincon, Alan Spatz, Wilson H Miller, Rahima Jamal, Réjean Lapointe, Anne-Marie Mes-Masson, Simon Turcotte, Kevin Petrecca, Sinziana Dumitra, Ari-Nareg Meguerditchian, Keith Richardson, Francine Tremblay, Beatrice Wang, May Chergui, Marie-Christine Guiot, Kevin Watters, John Stagg, Abdel Razaq Ahmad A Alyasin, Catalin Mihalcioiu, Sarkis Meterissian
Spatially mapping the immune landscape of melanoma using imaging mass cytometry. Science immunology 7 (70) (2022)
Célia Jacoberger Foissac, Isabelle Cousineau, Yacine Bareche, David Allard, Pavel Chrobak, Bertrand Allard, Sandra Pommey, Nouredin Messaoudi, Yannic McNicoll, Geneviève Soucy, Secil Koseoglu, Ricard Masia, Andrew C Lake, Heewon Seo, Christopher B Eeles, Neha Rohatgi, Simon C Robson, Simon Turcotte, Benjamin Haibe-Kains, John Stagg
CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer. Cancer immunology research (2022)
Marisa K Kilgour, Sarah MacPherson, Lauren G Zacharias, Abigail E Ellis, Ryan D Sheldon, Elaine Y Liu, Sarah Keyes, Brenna Pauly, Gillian A Carleton, Bertrand Allard, Julian Smazynski, Kelsey S Williams, Peter Hamilton Watson, John Stagg, Brad H Nelson, Ralph J DeBerardinis, Russell G Jones, Phineas T Hamilton, Julian J Lum
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer. Science advances 7 (4) (2021)
Yacine Bareche, Sandra Pommey, Mayra Carneiro, Laurence Buisseret, Isabelle Cousineau, Pamela Thebault, Pavel Chrobak, Laudine Communal, David Allard, Simon C Robson, Anne-Marie Mes-Masson, Diane Provencher, Rejean Lapointe, John Stagg
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer. Journal for immunotherapy of cancer 9 (3) (2021)
Lukas Franz Mager, Regula Burkhard, Nicola Pett, Noah C A Cooke, Kirsty Brown, Hena R Ramay, Seungil Paik, John Stagg, Ryan A Groves, Marco Gallo, Ian A Lewis, Markus B Geuking, Kathy D McCoy
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science (New York, N.Y.) 369 (6510) (2020)
Bertrand Allard, David Allard, Laurence Buisseret, John Stagg
The adenosine pathway in immuno-oncology. Nature reviews. Clinical oncology 17 (10) (2020)

John Stagg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John Stagg